Abstract |
Sinuleptolide and its congeners are diterpenes with a norcembranoid skeleton isolated from the soft coral genus Sinularia. These marine metabolites are endowed with relevant biological activities, mainly associated with cancer development. 5-epi-sinuleptolide has been selected as a candidate for target discovery studies through the application of complementary proteomic approaches. Specifically, a combination of conventional chemical proteomics based on affinity chromatography, coupled with high-resolution mass spectrometry and bioinformatics, as well as drug affinity responsive target stability (DARTS), led to a clear identification of actins as main targets for 5-epi-sinuleptolide. Subsequent in-cell assays, performed with cytochalasin D as reference compound, gave information on the ability of 5-epi-sinuleptolide to disrupt the actin cytoskeleton by loss of actin fibers and formation of F-actin amorphous aggregates. These results suggest the potential application of 5-epi-sinuleptolide as a useful tool in the study of the molecular processes impaired in several disorders in which actin is thought to play an essential role.
|
Authors | Elva Morretta, Roberta Esposito, Carmen Festa, Raffaele Riccio, Agostino Casapullo, Maria Chiara Monti |
Journal | Marine drugs
(Mar Drugs)
Vol. 15
Issue 10
(Oct 13 2017)
ISSN: 1660-3397 [Electronic] Switzerland |
PMID | 29027931
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- 5-episinuleptolide
- Actins
- Diterpenes
- Cytochalasin D
|
Topics |
- Actin Cytoskeleton
(drug effects, metabolism)
- Actins
(metabolism)
- Animals
- Anthozoa
(metabolism)
- Chromatography, Affinity
(methods)
- Cytochalasin D
(pharmacology)
- Diterpenes
(isolation & purification, pharmacology)
- HeLa Cells
- Humans
- Mass Spectrometry
(methods)
- Proteomics
(methods)
|